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Dr. Tedros Adhanom Ghebreyesus, director-general of the 
World Health Organisation (WHO), declared the COVID 
19 a global pandemic on March 11th, 2020.1 Since then, it 
has become a global public health crisis and has negatively 
impacted the global economy. Failure of the existing health 
systems to prevent massive disruption caused by COVID-
19 has emphasized a need to develop newer methods to 
control the spread of such pandemics.
Artificial Intelligence (AI) is defined as the study of “intel-
ligent agents,” which are devices that “perceive their 
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Abstract
Background: In the face of the current time-sensitive COVID-19 pandemic, the limited capacity of healthcare systems 
resulted in an emerging need to develop newer methods to control the spread of the pandemic. Artificial Intelligence (AI), 
and Machine Learning (ML) have a vast potential to exponentially optimize health care research. The use of AI-driven tools in 
LMIC can help in eradicating health inequalities and decrease the burden on health systems. Methods: The literature search 
for this Scoping review was conducted through the PubMed database using keywords: COVID-19, Artificial Intelligence 
(AI), Machine Learning (ML), and Low Middle-Income Countries (LMIC). Forty-three articles were identified and screened 
for eligibility and 13 were included in the final review. All the items of this Scoping review are reported using guidelines for 
PRISMA extension for scoping reviews (PRISMA-ScR). Results: Results were synthesized and reported under 4 themes. (a) 
The need of AI during this pandemic: AI can assist to increase the speed and accuracy of identification of cases and through 
data mining to deal with the health crisis efficiently, (b) Utility of AI in COVID-19 screening, contact tracing, and diagnosis: Efficacy 
for virus detection can a be increased by deploying the smart city data network using terminal tracking system along-with 
prediction of future outbreaks, (c) Use of AI in COVID-19 patient monitoring and drug development: A Deep learning system 
provides valuable information regarding protein structures associated with COVID-19 which could be utilized for vaccine 
formulation, and (d) AI beyond COVID-19 and opportunities for Low-Middle Income Countries (LMIC): There is a lack of financial, 
material, and human resources in LMIC, AI can minimize the workload on human labor and help in analyzing vast medical 
data, potentiating predictive and preventive healthcare. Conclusion: AI-based tools can be a game-changer for diagnosis, 
treatment, and management of COVID-19 patients with the potential to reshape the future of healthcare in LMIC.
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environment and take actions to maximize their chance of 
success at some goal.”2 A subset of AI is Machine learning 
(ML), which learns from trial and error basis and improves its 
performance on the results. ML has continued to show prom-
ising results in optimizing processes and resource allocation 
and preparing new data using versatile methods.3,4 Deep 
learning, a subset of ML, uses neural networks, which are one 
of the most beautiful programming paradigms ever invented 
(Figure 1). Neural networks specifically and artificial intelli-
gence in general have a vast potential to exponentially opti-
mize health care research, especially in an ongoing pandemic 
where time is of the essence. Clinical data, epidemiological 
data, and genetic data have to be all processed together to 
come up with the best possible prevention, diagnosis, and 
management of disease, and extrapolate it to public health 
measures.5,6 To tackle such variations, there is a high need for 
precise and integrated command and control system, and ML 
brings a solution to all these complex problems.3
This pandemic has put immense pressure on authorities to 
gather clinical, epidemiological, and public health data on 
coronavirus, and use it optimally to take appropriate and 
timely actions to control its spread, with minimum disruption 
of the economy and people’s lives. Artificial Intelligence-
driven tools have a great potential to make this process effort-
less, and arguably much better as compared to humans.7 One 
example is real-time data sharing through dashboards that 
have helped in understanding the spread of SARS-CoV-2 
coronavirus and assisted authorities to take measures to pro-
tect their communities. Machine learning algorithms have 
been put in place for the screening of SARS-CoV-2 assay 
through the use of a CRISPR-based virus detection system, 
which demonstrated high sensitivity and speed.8,9 For the 
screening of COVID-19 patients on large scale, Neural 
Network classifiers have been developed based on the 
patient’s distinct respiratory pattern.10 AI is not limited to 
screening patients but also assisting in therapeutics and 
treatment of COVID-19. AI has been incorporated in running 
clinical trials that test for the effectiveness of existing treat-
ments against SARS-CoV-2.11 Additionally, to propose and 
generate novel drug-like compounds against SARS-CoV-2, a 
deep learning-based drug discovery pipeline is being used.12
Most of these artificial intelligence-driven tools are seen 
to been reinforced and practiced in high-income countries. 
While in LMIC, there is still a lack of evidence on the use 
of artificial intelligence in the prevention, diagnosis, and 
treatment of the COVID-19 pandemic. AI use in LMIC can 
help in eradicating health inequalities and reduce the bur-
den on the health care systems.13 AI-based tools are already 
being explored to be used in LMIC, to ease the burden on 
resource-limited settings to improve outcomes.
Our Scoping Review aims to explore the use of AI and ML 
to combat COVID-19 and opportunities for LMIC to adapt 
and implement from these AI-driven tools to their settings for 
better outcomes and response to this COVID-19 pandemic.
Methods
This Scoping Review was drafted using the Preferred 
Reporting Items of Systematic Reviews and Meta-Analysis 
(PRISMA) guidelines and its extensions for scoping reviews 
(PRISMA-ScR).14
Literature Search Strategy
The literature search was conducted on PubMed for all the 
articles relevant to the scope of our research question from 
December 2019 till April 2020 for a period of 3 weeks. The 
Keywords were searched using Boolean operators “OR/
AND.” The search terms were: (“2019-nCoV” OR “corona-
virus” OR “COVID-19” OR “nCoV)” AND (“AI”) OR 
“Artificial Intelligence” AND (“ML”) OR “Machine 
Learning” AND “(LMIC)” OR “Low middle-income coun-
tries”). The literature search fields for keywords included 
Title, Abstract (Summary), and Keywords of the articles.
Eligibility Criteria
All articles related to Artificial Intelligence (AI) or its subset 
(Machine learning, Deep Neural Networks) and clinical, epi-
demiological, or public health aspect of COVID-19 were 
included. Articles related to basic sciences and phylogenetics 
of COVID-19 were excluded. All non-English articles were 
excluded as well.
Selection of Sources of Evidence
The studies were selected through an independent litera-
ture search by two separate reviewers, RA and MN. After 
identifying and removing the duplicate articles data extrac-
tion and synthesis was performed. All reporting was done 
following the PRISMA flow diagram (Figure 2).
Figure 1. AI, ML, and deep neural networks: The relationship.
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Data Charting Process
All the included articles were listed in a table form reporting 
study title, date of publication, journal of publication, and 
key findings of all included studies were tabulated (Tables 1 
and 2). While doing data charting, the following data items 
were extracted: Study design, Data sources for AI develop-
ment or evaluation, category of AI, included intervention/s, 
country of study, study aims, and study findings (results)
Synthesis of Results
Results of the study were synthesized based on formulated 
4 themes(categories) identified through literature review 
following PRISMA guidelines of result reporting and syn-
thesis. The articles were grouped based on these 4 themes: 
COVID-19 pandemic and the need of AI, Utility of AI in 
COVID-19 screening, contact tracing and diagnosis, Use of 
AI in COVID-19 patient monitoring and drug development, 
AI beyond COVID-19 & opportunities for Low-Middle 
Income Countries (LMIC).
Selection of Sources of Evidence
The literature search carried out for this scoping review was 
done on PubMed using a combination of the keywords 
Artificial Intelligence (AI), COVID-19, Machine Learning 
(ML), and Low Middle-Income Countries (LMIC). After 
removing duplicates, a total of 35 articles were identified. 
These 35 articles were screened, and 13 articles were excluded 
which did not meet our inclusion criteria as they were not 
about either AI, or ML, or COVID-19. Full-text review of the 
remaining 22 articles was done and 9 were excluded because 
they either were not under the scope of our study or not men-
tioning specific AI applications in use. The remaining 13 arti-
cles were considered for the final review. All articles that were 
reviewed were in the English language. (Figure 2)
Characteristics and Results of Sources of 
Evidence
Characteristics of the selected articles are presented in Table 
1, while aims/purposes and highlights/key results are pre-
sented in Table 2.
Results
Four Themes Were Identified From the Selected 
Articles
1. COVID-19 pandemic and the need of AI (See 
Figure 3)
2. The utility of AI in COVID-19 screening, contact 
tracing, and diagnosis
Records idenfied through 
database searching using key 
words: AI, COVID, and ML and 
LMICs (n = 43)
Addional records idenfied 
through other sources
(n = 0)






Studies included in 
result synthesis
(n = 13)
Records excluded because 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 Journal of Primary Care & Community Health 
3. Use of AI in COVID-19 patient monitoring and 
drug development
4. AI beyond COVID-19 and opportunities for Low-
Middle Income Countries (LMIC)
COVID-19 Pandemic and the Need for AI
For a rapidly spreading pandemic like COVID-19, AI can 
make medical treatments more efficient in several ways. It can 
assist to increase the speed and accuracy of identification of 
cases.18,21,24 For instance, the average processing time for a 
trained deep learning algorithm to identify COVID-19 on CT 
chest was 4.51 seconds, as compared to an average of 10 min-
utes 9 seconds required by a radiologist.15,26 This means that if 
an AI algorithm is trained to have equal accuracy as a radiolo-
gist, it will report results about 135 times faster than a radiolo-
gist and can work round the clock without risking errors from 
fatigue. Extensive training and experience required by a radi-
ologist to differentiate CT chest for COVID-19 patients, which 
may be very similar to CT chest in other types of pneumonia, 
will also be significantly longer as compared to “training” 
required by AI.18 Since the identification of disease is critical 
for treatment and infection control in a pandemic, faster AI will 
produce much more desirable results than slower humans.15,17
Another potential application of AI is to position patients 
for radiological imaging. Healthcare workers can accurately 
position patients using cameras, speakers, and AI-assistance 
to ensure adequate position from a control room, without 
requiring direct contact with potential patients and risking 
the infection.24,18
To understand the COVID-19 outbreak, data mining 
methods could be utilized for exploratory and traditional 
analysis to deal with the health crisis efficiently.23 Delivery of 
accurate and cost-effective tests for COVID-19 diagnosis is a 
challenge, that can be overcome by the use of AI technology 
to reduce the burden on health systems in resource-limited 
settings especially in LMIC.16,19 Conventional AI-tools does 
not provide optimal results if less data is available so cross-
population train/test-based AI-based models are required 
which can detect viruses in one country with the help of a 
model trained in another country to make automated detec-
tion of COVID-19, which will help in the containment of the 
virus.7 The deep-learning prediction models and the resultant 
risk stratification may come in handy in formulating clinical 
judgment in a time-critical and resource-limited settings.27
The Utility of AI in COVID-19 Screening, Contact 
Tracing, and Diagnosis
Chest CT is deployed as a rapid and reliable technique for 
COVID-19 screening.15 Suspected cases and high-risk 
groups can be screened and identified by using AI- algo-
rithms (eg, with a travel or exposure history).16,17,21 These 
patients can be divided according to disease severity, thus 
the high-risk groups can be isolated and diagnosis can be 
confirmed using laboratory-based PCR tests.7,16 The spread 
of the virus could be tracked, and the most worst-hit areas 
can be timely identified.17 This will help in time-effective 
controlling, monitoring, and prevention of the pandemic.16,17 
Since COVID-19 presents with similar features as other 
Figure 3. Synthesis of evidence.
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types of lung infections and pathologies, a deep learning 
model can accurately detect COVID-19 as distinct from 
other types of respiratory diseases with a sensitivity of 90% 
and specificity of 96% respectively.15,25 AI-driven tools can 
detect tiny features in radiology data (pixel-level nodules) 
and AI-empowered image segmentation can perform accu-
rate and efficient diagnosis and analysis, which may not be 
picked up by radiologists.7,18
Efficacy for virus detection can also be increased by 
employing the smart city data network using a terminal 
tracking system and data sharing for better urban manage-
ment and the location of the next outbreak could be pre-
dicted.20,25 Using a mobile-based survey, COVID-19 can be 
identified and controlled in the population under quaran-
tine.21 Susceptible people can also be identified based on 
personalized genetics and physiological characteristics.24 A 
study used a modified Susceptible-Exposed-Infected-
Recovered (SEIR) epidemiological model to effectively 
determine the COVID-19 peaks and the results were also 
analyzed through the Long Short-Term Memory (LSTM) 
model (Artificial Neural Network)). The model was trained 
on the data from the SARS epidemic and incorporation of 
COVID-19 epidemiological characteristics, such as the 
odds of transmission and incubation, it predicted the peak 
for new infections on February 4th in China. When the 
LTSM-predicted curve was compared with the actual num-
ber of new confirmed cases between January 22 and 
February 10, there was a remarkable fit between the both.10 
AI-based prediction models and internet sources could also 
be utilized for pandemic forecasting.22,23 This suggests that 
the peak for the pandemic can be predicted, and as Peter 
Hotez (Baylor College of Medicine, Houston, TX, USA) 
stated, AI could also predict the effect of seasonality on the 
COVID-19 outbreak, so adequate measures can be taken 
timely for its containment and spread.25
Use of AI in COVID-19 patient monitoring and 
drug development
AI could be adopted as a tool for patient management. 
Online medical chatbots could help patients in recognition 
of their symptoms and guide the population on hand 
hygiene.16 It can predict the risk of mortality by investigat-
ing the previous data of patients and can monitor the day to 
day updates of the patient by acquiring data through visual 
sensors like Red, Green, Blue (RGB), time of flight (TOF), 
pressure imaging, or thermal (FIR) cameras so that patient 
supervision is automated.17,18
AI can facilitate the discovery of drugs for treatment 
against COVID-19 by speeding up drug testing which is not 
possible by human labor.16,17 Utilizing AI methods, 
Benevolent AI and Imperial College London have recently 
reported that a drug used for treatment of rheumatoid arthri-
tis “Baricitinib,” can be used effectively against the virus, 
while Insilico Medicine based in Hong Kong also published 
that they were able to design 6 new molecules that could 
stop viral replication utilizing AI algorithms.25 Alpha Fold, 
(a deep learning system) created by Google DeepMind, pro-
vided valuable information about protein structures related 
with COVID-19 which could be utilized for vaccine formu-
lation, which could have taken significantly longer by tradi-
tional experimental approaches.24 Advanced machine 
learning technology is required to analyze vast amounts of 
treatment data for COVID-19, all around the world and it 
could be shared among hospitals using AI-tools for better 
treatment of patients globally.24
AI beyond COVID-19 and opportunities for Low-Middle Income 
Countries (LMIC). Moritz Kraemer, a spatial epidemiologist 
(University of Oxford, Oxford, UK) stated that “AI is rele-
vant to this outbreak and in the future, it will become even 
more so.”25 AI technology has been successful in diagnos-
ing COVID-19 through CT scans. This ability to extract 
information from chest CT has made deep learning an effi-
cient tool in the field of radiology for making clinical deci-
sions that is, for disease diagnosis, tracking, and 
prognosis.15,18 Unnecessary hospital visits could be avoided 
by using Phone-based AI software that can assist in the 
detection and recording of data from patients (eg, daily tem-
perature and symptoms) which will reduce the burden on 
clinicians and health care systems in LMIC.16,25,28 There is a 
paucity of financial, material, and human resources in 
LMIC, AI can not only minimize the workload on human 
labor but it will also help in analyzing vast medical data and 
assist in decision making for patient treatment.7,17 Apart 
from data collection, AI can also assist in biomedical 
researches, pharmaceutical chain management, and remote 
patient monitoring which will help improve health care in 
LMIC and play a pivotal role in predictive and preventive 
health care.17,19 The health care systems could be effectively 
transformed by utilizing AI-based tools which will allow 
for data sharing and analysis and better urban health man-
agement.20 This can also assist policymakers and health-
care-related managers in planning health care resources 
accordingly, as AI-based models hold the potential to pre-
dict future epidemics and can help to predict outcomes, 
understanding the trends in healthcare and model risk asso-
ciations accordingly.10,16,22,23
Strengths and Limitations
Our study is based on current evidence on AI and ML use in 
COVID-19 pandemic and we have specifically highlighted 
LMIC aspects to our review which is a need of time. We 
have used rigorous and authentic methodology for reporting 
our review that is, PRISMA-ScR.
The Limitations of our scoping review are associated 
with databases that we included for our literature synthesis, 
we searched for the most popular literature indexing data-
base “PubMed” as the topic is associated with Information 
10 Journal of Primary Care & Community Health 
technology, bio-informatics, and latest scientific develop-
ments that have a limited publication coverage. We may 
have missed some grey literature, and we focused our 
search on scientific and clinical related aspects of COVID-
19 because our scope was to limit our search to the use of AI 
in medical technology specifically in the COVID-19 pan-
demic and LMIC perspective to it.
However, we have observed that with the emerging use 
of AI we can further aim for broader scoping reviews in the 
future.
Conclusion
AI has not only reduced the burden on health care systems by 
cost-effective and faster detection of COVID-19, screening, 
and diagnosis but it has also helped predict the location of the 
outbreak and future prediction of such outbreaks to allow suf-
ficient preparedness at healthcare levels, this may aid the 
LMIC to prepare and allocate their healthcare resources in 
advance to avoid the collapse of healthcare systems. Hence it 
could be utilized as an effective tool by LMIC to ease the 
burden on their health care systems in several ways like plan-
ning, mitigation, diagnosis, and treatment of patients. The 
future of healthcare lies in AI-based tools and further utilities 
need to be explored in the coming times.
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